Expert Panel: Role of Genomics and Genetics in Prostate Cancer

  Featured Video

Treatment Advances and Management of ES-SCLC

    Featured Video

ASCO 2025: Developments in Gynecologic Oncology

Using PET Radiopharmaceutical to Predict Advanced MCL Outcomes

FDA Approves Zenocutuzumab in NSCLC/Pancreatic Cancer

Zenocutuzumab is now approved for patients with NRG1 fusion-positive NSCLC or pancreatic adenocarcinoma.

Non–Small Cell Lung Cancer (NSCLC) with Actionable Mutations

  Featured Video

FDA Approves Subcutaneous Atezolizumab Plus Hyaluronidase-tqjs in Multiple Soft Tumor Indications

Relapsed/Refractory Multiple Myeloma Algorithm

  Featured Video